Position in PHVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$160,569,809
+$29,509,471 QoQ
Shares Held
4,643,430
+0.1% QoQ
Ownership
6.61%
of shares outstanding
% of Portfolio
30.92%
of 13F equity value
Holder Rank
#4
of 124 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026venBio Partners LLC holds $519,380,252 across 7 Biotechnology names. PHVS ranks #1 (30.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHVS |
Pharvaris N.V.
This page
|
4,643,430 | $160,569,809 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
5,266,697 | $144,149,496 | |
| 3 | ALMS |
Alumis Inc.
|
4,528,408 | $127,429,401 | |
| 4 | ACHV |
Achieve Life Sciences, Inc.
|
5,914,720 | $38,623,121 | |
| 5 | ALXO |
Alx Oncology Holdings Inc
|
12,884,638 | $26,671,200 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
472,194 | $17,192,583 | |
| 7 | LYEL |
Lyell Immunopharma, Inc.
|
337,697 | $4,744,642 |
All Filings in PHVS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $160,569,809 | 4,643,430 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $131,060,338 | 4,639,304 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $128,740,686 | 4,639,304 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $115,750,634 | 4,639,304 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $75,491,750 | 4,289,304 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $67,342,072 | 4,289,304 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $82,225,957 | 4,289,304 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $79,437,910 | 4,289,304 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $80,638,915 | 4,289,304 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $99,125,815 | 4,289,304 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $137,992,087 | 4,919,504 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $89,003,704 | 4,264,672 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $64,567,134 | 4,264,672 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,353,921 | 2,278,575 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $25,837,987 | 2,296,710 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $17,615,765 | 2,296,710 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $50,862,067 | 2,301,451 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $41,770,526 | 2,303,310 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $33,144,630 | 2,303,310 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $40,837,686 | 2,303,310 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $42,910,665 | 2,303,310 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $64,446,613 | 2,303,310 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||